Moxifloxacin is indicated for the treatment of plague, acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, community-acquired pneumonia CAP, skin structure-related infections, and both complicated and uncomplicated intra-abdominal infections.

Mild to moderate side effects have been observed. Side effects such as nausea, vomiting, sweating, stomach cramps or tenderness, itching, loss of appetite, headache, irritability, dry mouth, and bone pain.

To be prescribed cautiously in patients with hypokalemia, any seizure, or CNS-related disorders; not to be prescribed in patients with diarrhea as it may worsen it.

This drug is contraindicated in patients with a history of low blood sugar, in patients with a low seizure threshold, and in patients with hypersensitivity to the drug.

A single-dose tablet of 400 mg is to be administered orally 24 hours after meals.

We have established our roots in other countries as well, such as Egypt, Colombia, Burundi, Hong Kong China, East Timor, Cambodia, and Lebanon

Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai